BG Medicine, Inc. (Nasdaq: BGMD) announced the presentation of new clinical research data on the BGM Galectin-3 test in heart ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE